Same as BPC-157 — angiogenesis, growth-factor modulation, tendon/GI healing in animal models.
Reference facts
- Also known as
- BPC-157 Arginate Salt, PDA
- Category
- Healing & Tissue Repair
- Mechanism of action
- Same as BPC-157 — angiogenesis, growth-factor modulation, tendon/GI healing in animal models.
- Targets
- Same as BPC-157
- Indications under research or approved
- Research only
- Regulatory status (reference entry)
- Not FDA-approved; same regulatory status as BPC-157
- Half-life
- Comparable to BPC-157 acetate
- Sequence
- GEPPPGKPADDAGLV
- Sequence notes
- BPC-157 backbone (15-residue, 'pentadeca') as the arginate salt — promoted as more stable in solution than the acetate.
- Molecular weight (Da)
- 1419
- First reported
- 2023
Primary References
Explore research articles about Pentadeca Arginate (PDA)
This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.